briviact 25 mg film coated tablets
neopharm ltd, israel - brivaracetam - film coated tablets - brivaracetam 25 mg - brivaracetam - briviact is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.mg/kg/day.
briviact 50 mg film coated tablets
neopharm ltd, israel - brivaracetam - film coated tablets - brivaracetam 50 mg - brivaracetam - briviact is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.
briviact 75 mg film coated tablets
neopharm ltd, israel - brivaracetam - film coated tablets - brivaracetam 75 mg - brivaracetam - briviact is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.
briviact oral solution
neopharm ltd, israel - brivaracetam - solution (oral) - brivaracetam 10 mg / 1 ml - brivaracetam - briviact is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.
briviact 10 mg filmtabletten
ucb-pharma sa - brivaracetamum - filmtabletten - brivaracetamum 10 mg, carmellosum natricum conexum corresp. natrium 0.6 mg, lactosum monohydricum 45 mg, betadexum, lactosum 45.1 mg, magnesii stearas, pellicule: poly(alcohol vinylicus), talcum, macrogolum 3350, e 171 pro compresso obducto. - antiepileptikum - synthetika
briviact 25 mg filmtabletten
ucb-pharma sa - brivaracetamum - filmtabletten - brivaracetamum 25 mg, carmellosum natricum conexum corresp. natrium 0.75 mg, lactosum monohydricum 48.5 mg, betadexum, lactosum 48.25 mg, magnesii stearas, pellicule: poly(alcohol vinylicus), talcum, macrogolum 3350, e 171, e 172 (flavum), e 172 (nigrum) pro compresso obducto. - antiepileptikum - synthetika
briviact 50 mg filmtabletten
ucb-pharma sa - brivaracetamum - filmtabletten - brivaracetamum 50 mg, carmellosum natricum conexum corresp. natrium 1.5 mg, lactosum monohydricum 97 mg, betadexum, lactosum 96.5 mg, magnesii stearas, pellicule: poly(alcohol vinylicus), talcum, macrogolum 3350, e 171, e 172 (flavum), e 172 (rubrum) pro compresso obducto. - antiepileptikum - synthetika
briviact 75 mg filmtabletten
ucb-pharma sa - brivaracetamum - filmtabletten - brivaracetamum 75 mg, carmellosum natricum conexum corresp. natrium 2.25 mg, lactosum monohydricum 145.5 mg, betadexum, lactosum 144.75 mg, magnesii stearas, pellicule: poly(alcohol vinylicus), talcum, macrogolum 3350, e 171, e 172 (flavum), e 172 (rubrum), e 172 (nigrum) pro compresso obducto. - antiepileptikum - synthetika
briviact 100 mg filmtabletten
ucb-pharma sa - brivaracetamum - filmtabletten - brivaracetamum 100 mg, carmellosum natricum conexum corresp. natrium 3 mg, lactosum monohydricum 194 mg, betadexum, lactosum 193 mg, magnesii stearas, pellicule: poly(alcohol vinylicus), talcum, macrogolum 3350, e 171, e 172 (flavum), e 172 (nigrum) pro compresso obducto. - antiepileptikum - synthetika
briviact 10 mg/ml solution buvable
ucb-pharma sa - brivaracetamum - solution buvable - brivaracetamum 50 mg, acidum citricum, natrii citras dihydricus, carmellosum natricum, sucralosum, sorbitolum 839.5 mg, glycerolum, aromatica, aqua purificata, e 218 5 mg ad solutionem pro 5 ml corresp. natrium 5.8 mg. - antiépiléptique - synthetika